Tech Company Financing Transactions
BLOOM43 by PLEXaa Funding Round
BLOOM43 by PLEXaa, based in London, secured $4.5 million in funding from TCP Venture Capital and private investors.
Transaction Overview
Company Name
Announced On
7/8/2025
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Seed
Investors
TCP Venture Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the imminent U.S. launch of BLOOM4³, strengthen its position ahead of the planned Series A round.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Makerversity, Somerset House, Victoria Embankment
London, WC2R 1LA
UK
London, WC2R 1LA
UK
Phone
Undisclosed
Website
Email Address
Overview
Plexaa is a pioneering UK-based MedTech company focused on improving surgical outcomes through devices and digital products. Its flagship device, BLOOM43, enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect one in three women undergoing breast surgery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Saahil Mehta
Browse more venture capital transactions:
Prev: 7/8/2025: Huspy venture capital transaction
Next: 7/8/2025: APFusion venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs